アプリケーションノート：バイオ医薬品の創薬を加速するAI/MLアプローチ

バイオ医薬品の開発では、AIをはじめとするデータサイエンス手法が効率向上とリスク軽減に大きく貢献しますが、その成功には高品質で構造化されたデータへのアクセスが不可欠です。Genedata Biologics^®は、ワークフロー全体のデータ取得と評価を自動化することで、抗体・免疫療法・ワクチンなどの開発を迅速かつ高精度に進めるための堅牢なデータ基盤を提供します。

In biotherapeutic development, data science approaches such as artificial intelligence (AI) have the potential to significantly improve efficiency and reduce failure rates. However, the success of these methods depends on access to high-quality, structured data.

Genedata Biologics^® provides a robust data foundation that supports advanced data science applications, including the development of analytical pipelines and the training of machine learning (ML) models. By automating data capture and evaluation across biotherapeutics workflows, the platform streamlines the development of novel antibodies, immunotherapies, and vaccines, enabling teams to advance from concept to candidate with greater speed, precision, and confidence.